FINANCIALS

LGNYZ Ligand Pharmaceuticals Inc 886163

Income Statement
Revenue	lgnd-20241231	167,133,000
Net Income	lgnd-20241231	-4,032,000
Profit Margin		-2.41%

Balance Sheet
Current Assets	331,559,000
Assets	941,774,000
Current Liabilities	37,112,000
Liabilities	111,335,000
Equity	830,439,000

Cash Flow Statement
Operating Cash Flow	97,047,000
Investing Cash Flow	-143,664,000

Market Analysis
BVPS	10431.39
PB	0.03
PS	0.64
FCF	-46,617,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view LGNYZ documents filed with the SEC.

LGNYZ Filings Clear

View A List of Tickers